Doxycycline and Its Effects on Colorectal Cancer Treatment
Author Information
Author(s): Sagar Jayesh, Sales Kevin, Dijk Sas, Taanman JanWillem, Seifalian Alexander, Winslet Mark
Primary Institution: University College London
Hypothesis
Does doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
Conclusion
Doxycycline has a role in inducing apoptosis in colorectal cancer cells but does not show any synergistic effects with platinum compounds.
Supporting Evidence
- Doxycycline increased caspase 3 activity compared to control.
- Caspase 3 activity was lower in cells treated with both doxycycline and platinum compounds.
- The study suggests possible caspase-independent actions of doxycycline.
Takeaway
Doxycycline can help kill cancer cells, but it doesn't work better when combined with certain chemotherapy drugs.
Methodology
HT 29 colorectal cancer cells were treated with cisplatin and oxaliplatin with or without doxycycline, and caspase 3 gene expression and activity were measured.
Limitations
The study did not explore all potential mechanisms of action for doxycycline.
Statistical Information
P-Value
p = 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website